Asston Pharmaceuticals Financials

BSE: 544445

₹109.95

₹4.30 (4.07%)

As on 04-Sep-2026IST

Market cap

₹120 Cr

Revenue (TTM)

₹25 Cr

P/E Ratio

31.1

P/B Ratio

2.4

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Operating Revenue	25.04	15.59	6.54	9.60	--	--
Total Income	25.61	15.84	7.19	10.55	--	--
Total Expenditure	18.88	13.04	5.02	9.95	--	--
EBITDA	6.16	2.55	1.52	-0.36	--	--
Depreciation	0.08	0.05	0.04	0.01	--	--
EBIT	6.08	2.50	1.48	-0.36	--	--
Interest	0.95	0.93	0.72	0.43	--	--
Other Income	0.57	0.25	0.65	0.96	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	5.70	1.82	1.41	0.16	--	--
Provision for Tax	1.37	0.46	0.36	0.05	--	--
Profit after Tax	4.33	1.36	1.06	0.11	--	--

Liabilities (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Shareholder's Funds	10.72	6.39	1.99	0.93	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	2.39	1.81	1.92	1.01	--	--
Current Liabilities	14.99	12.06	9.79	7.56	--	--
Total Liabilities	28.12	20.26	13.69	9.49	--	--

Assets (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Non-Current Assets	1.08	1.92	3.00	2.11	--	--
Current Assets	27.02	18.34	10.69	7.38	--	--
Total Assets	28.12	20.26	13.69	9.49	--	--
Total Debt*	7.26	6.82	5.25	3.31	--	--
Net Current Assets	12.03	6.28	0.91	-0.18	--	--
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	-0.16	-3.80	-0.32	-1.19	--	--
Cash Flow from Investing Activities	0.87	-0.01	-0.91	0.00	--	--
Cash from Financing Activities	-0.51	3.69	1.21	1.29	--	--
Net Cash Inflow / Outflow	0.19	-0.12	-0.01	0.10	--	--

Financials Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS (₹)	6.90	2.17	1.89	0.20	--	--
Cash EPS (₹)	7.03	2.25	1.95	0.21	--	--
Adjusted Book Value (₹)	17.09	10.19	3.55	1.66	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	-0.26	-48.48	-4.51	-16.95	--	--
Free Cash Flow per Share (₹)	-3.80	-60.06	-23.12	-23.41	--	--

Profitability Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	42.64	26.90	37.20	13.97	--	--
ROE (%)	50.56	32.47	72.49	11.90	--	--
ROA (%)	17.89	8.01	9.11	1.17	--	--
EBIT Margin (%)	24.28	16.01	22.63	-3.79	--	--
Net Margin (%)	16.89	8.59	14.69	1.05	--	--
Cash Profit Margin (%)	17.60	9.05	16.73	1.24	--	--

Growth Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	60.65	138.39	-31.89	--	--	--
EBIT Growth (%)	143.60	68.64	506.71	--	--	--
Net Profit Growth (%)	217.95	28.74	855.33	--	--	--
EPS Growth (%)	217.94	14.96	855.34	--	--	--
Book Value Growth (%)	67.66	221.89	113.70	--	--	--

Valuation Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.98	2.71	2.68	6.45	--	--
Close Price (₹)	--	--	--	--	--	--
High Price (₹)	--	--	--	--	--	--
Low Price (₹)	--	--	--	--	--	--
Market Cap (₹ Cr)	--	--	--	--	--	--

Solvency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	0.68	1.07	2.64	3.56	--	--
Short term debt to equity ratio	0.35	0.71	1.58	2.49	--	--
Current Ratio	1.80	1.52	1.09	0.98	--	--
Quick Ratio	1.75	1.40	0.94	0.91	--	--
Interest Coverage	7.00	2.95	2.96	1.37	--	--

Operating Efficiency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	98.04	103.63	131.67	66.71	--	--
Asset Turnover	1.04	0.92	0.56	1.01	--	--
Receivable days	296.65	289.92	419.04	243.49	--	--
Inventory Days	15.72	34.42	55.94	19.14	--	--
Payable days	190.57	250.27	685.40	246.66	--	--
Cash Conversion Cycle	121.80	74.08	-210.43	15.97	--	--